Name | TSENTR SEMEYNOY MEDITSINY ALMITA, OOO |
---|
INN | 5407050847 |
---|
KPP | 540701001 |
---|
OGRN | 1085407009710 |
---|
OKPO | 86819347 |
---|
Address | 630132, Novosibirskaya Oblast', g. Novosibirsk, ul. Zheleznodorozhnaya, d. D.12/1, of. 6 |
---|
Phone | 359-71-44 |
|
OKVED code | Type | Name of activity type |
---|
86 | Core activity | Health service | 82.99 | Additional activity | Other business support services to businesses and individuals not otherwise specified | 86.10 | Additional activity | Hospitals | All types of activities | 86.21 | Additional activity | General practice | 86.23 | Additional activity | Dental practice | 86.90.9 | Additional activity | Other independent activities in health care |
Registration date | 07.06.2008 |
---|
Registering department | Inspektsiya Federal'noy nalogovoy sluzhby po Zheleznodorozhnomu rayonu g. Novosibirska |
---|
|
TSENTR SEMEYNOY MEDITSINY ALMITA, OOO (Novosibirsk Oblast; INN 5407050847) was registered on 7 Jun 2008. The company's authorized capital as of July 1, 2012 was 60000 rub. Type of ownership of TSENTR SEMEYNOY MEDITSINY ALMITA, OOO - Limited liability companies. Form of ownership of TSENTR SEMEYNOY MEDITSINY ALMITA, OOO - Private property. Principal activities of TSENTR SEMEYNOY MEDITSINY ALMITA, OOO: health service (86), other business support services to businesses and individuals not otherwise specified (82.99), hospitals (86.10). |
Economic indicators2023
Net profit (RAS) of TSENTR SEMEYNOY MEDITSINY ALMITA, OOO dropped in 2023 by 14.07% to 9.14 million RUB from 10.64 million RUB over the same period in 2022, the company informed. Revenue increased in the accounting period by 30.74% to 149.99 million RUB from 114.72 million RUB over 2022. 2022
Net profit (RAS) of TSENTR SEMEYNOY MEDITSINY ALMITA, OOO grew over 2022 1.59 times to 10.64 million RUB from 6.70 million RUB over 2021, the company informed. Revenue increased in the accounting period by 18.44% to 114.72 million RUB from 96.86 million RUB over 2021. 2021
Net profit (RAS) of TSENTR SEMEYNOY MEDITSINY ALMITA, OOO dropped in 2021 by 20.93% to 6.70 million RUB from 8.48 million RUB over the same period in 2020, the company informed. Revenue increased in the accounting period by 16.37% to 96.86 million RUB from 83.23 million RUB over 2020. 2020
Net profit (RAS) of TSENTR SEMEYNOY MEDITSINY ALMITA, OOO grew over 2020 by 39.07% to 8.48 million RUB from 6.10 million RUB over 2019, the company informed. Revenue decreased in the accounting period by 8.43% to 83.23 million RUB from 90.90 million RUB in 2019. 2019
Net profit (RAS) of TSENTR SEMEYNOY MEDITSINY ALMITA, OOO grew over 2019 1.83 times to 7.02 million RUB from 3.83 million RUB over 2018, the company informed. Revenue increased in the accounting period by 13.48% to 90.90 million RUB from 80.11 million RUB over 2018; sales profit went up 1.64 times to 8.55 million RUB from 5.22 million RUB. 2018
Net profit (RAS) of TSENTR SEMEYNOY MEDITSINY ALMITA, OOO made up 0 RUB over 2018 compared to net loss of 5.50 million RUB over 2017, the company informed. Revenue decreased in the accounting period Infinity times to 0.00 thousand RUB from 69.51 million RUB in 2017; sales profit made up 0 compared to net loss of 3.58 million RUB. 2017
Net loss (RA) of TSENTR SEMEYNOY MEDITSINY ALMITA, OOO made up 5.50 million RUB over 2017 compared to net profit of 2.66 million RUB over 2016, the company informed. Revenue increased in the accounting period by 11.77% to 69.51 million RUB from 62.19 million RUB over 2016; sales loss made up 3.58 million RUB compared to sales profit of 3.98 million RUB. 2016
Net profit (RAS) of TSENTR SEMEYNOY MEDITSINY ALMITA, OOO dropped in 2016 by 32.78% to 2.66 million RUB from 3.96 million RUB over the same period in 2015, the company informed. Revenue increased in the accounting period by 16.09% to 62.19 million RUB from 53.57 million RUB over 2015; sales profit fell by 27.79% to 3.98 million RUB from 5.51 million RUB. 2014
Net profit (RAS) of Tsentr semeynoy meditsiny ALMITA, OOO grew over 2014 1.96 times to 2.29 million RUB from 1.17 million RUB over 2013, the company informed. Revenue increased in the accounting period by 17.55% to 42.41 million RUB from 36.07 million RUB over 2013; sales profit went up 1.74 times to 3.30 million RUB from 1.90 million RUB. 2013
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|